Calidi Biotherapeutics, Inc. Debt Instrument, Face Amount
Calidi Biotherapeutics, Inc. (CLDI) had Debt Instrument, Face Amount of $600.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2026-03-27
- 2025-09-30: Debt Instrument, Face Amount $600.00K.
- 2025-06-30: Debt Instrument, Face Amount $975.00K.
- 2025-03-31: Debt Instrument, Face Amount $1.35M.
- 2024-12-31: Debt Instrument, Face Amount $3.00M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2025-09-30 | $600.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $975.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $1.35M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $3.00M 10-K · filed 2026-03-27 |
| 2024-09-30 | $4.80M 10-Q · filed 2024-11-12 |
| 2024-09-27 | $200.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $4.40M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $7.20M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $2.50M 10-K · filed 2025-03-31 |
| 2023-09-30 | $4.75M 10-Q · filed 2023-11-14 |
| 2022-12-31 | $5.26M 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |